Gerhard Hamilton
- Oncology top 2%
- Lung Cancer Research Studies 35
- Cancer Cells and Metastasis 18
- Peptidase Inhibition and Analysis 14
- Drug Transport and Resistance Mechanisms 13
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 10
- Gastroenterology top 5%
-
- Lung Cancer Treatments and Mutations 10
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 27
-
- Cancer therapeutics and mechanisms 20
- Co-authors
- Barbara H. RathUlrike OlszewskiLukas KlamethMaximilian J. HochmairG. BischofMartin RieglerEnrico P. CosentiniErnst Ulsperger
- Journals
- Cancers (5 papers)International Journal of Oncology (5 papers)Expert Opinion on Drug Metabolism & Toxicology (5 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Gerhard Hamilton
155 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 133
- Oncology 1.5k
- Cancer Research 456
- Gastroenterology 114
- Pulmonary and Respiratory Medicine 672
- Epidemiology 682
Countries citing papers authored by Gerhard Hamilton
This map shows the geographic impact of Gerhard Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Hamilton more than expected).
Fields of papers citing papers by Gerhard Hamilton
This network shows the impact of papers produced by Gerhard Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Hamilton. The network helps show where Gerhard Hamilton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gerhard Hamilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 17 | |
| 3 | 2022 | 14 | |
| 4 | 2021 | 16 | |
| 5 | 2019 | 2 | |
| 6 | 2019 | 14 | |
| 7 | 2016 | 1 | |
| 8 | 2012 | 17 | |
| 9 | 2010 | 49 | |
| 10 | 2010 | 94 | |
| 11 | 2009 | 14 | |
| 12 | 2006 | 13 | |
| 13 | 2005 | 10 | |
| 14 | 2003 | 249 | |
| 15 | 1999 | 29 | |
| 16 | 1998 | 10 | |
| 17 | 1996 | 24 | |
| 18 | 1995 | 268 | |
| 19 | 1995 | 2 | |
| 20 | 1993 | 35 |
About Gerhard Hamilton
Gerhard Hamilton is a scholar working on Oncology, Transplantation, Cancer Research, Epidemiology and Molecular Biology, having authored 160 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (35 papers), Neuroendocrine Tumor Research Advances (27 papers), Cancer therapeutics and mechanisms (20 papers), Cancer Cells and Metastasis (18 papers), Peptidase Inhibition and Analysis (14 papers), Drug Transport and Resistance Mechanisms (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer, Hypoxia, and Metabolism (10 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (456 citations), Gastroenterology (114 citations), Pulmonary and Respiratory Medicine (672 citations) and Epidemiology (682 citations). Gerhard Hamilton has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Barbara H. Rath, Ulrike Olszewski, Lukas Klameth, Maximilian J. Hochmair, G. Bischof, Martin Riegler, Enrico P. Cosentini, Ernst Ulsperger, Robert Zeillinger and W. Feil. Their work appears in journals such as Cancers, International Journal of Oncology, Expert Opinion on Drug Metabolism & Toxicology, Expert Opinion on Biological Therapy and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.